{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:31Z","timestamp":1792181731091,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0490000"],"award-info":[{"award-number":["XDB0490000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0703600"],"award-info":[{"award-number":["2021YFF0703600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2309400"],"award-info":[{"award-number":["2024YFC2309400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303300"],"award-info":[{"award-number":["2022YFC2303300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400777"],"award-info":[{"award-number":["32400777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ymthe.2025.08.022","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:37:10Z","timestamp":1755621430000},"page":"5470-5488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recombinant live attenuated measles virus-based vaccines inducing comprehensive protection against Ebola and Marburg viruses"],"prefix":"10.1016","volume":"33","author":[{"given":"Junhui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-5535","authenticated-orcid":false,"given":"Xinghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengguo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.08.022_bib1","first-page":"1","article-title":"The aetiology of an unknown human infection transmitted by monkeys (preliminary communication)","volume":"13","author":"Siegert","year":"1968","journal-title":"Ger. Med. Mon."},{"key":"10.1016\/j.ymthe.2025.08.022_bib2","first-page":"521","article-title":"Detection of the \"Marburg Virus\" in patients","volume":"13","author":"Siegert","year":"1968","journal-title":"Ger. Med. Mon."},{"key":"10.1016\/j.ymthe.2025.08.022_bib3","first-page":"271","article-title":"Ebola haemorrhagic fever in Zaire, 1976","volume":"56","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ymthe.2025.08.022_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60733-2","article-title":"Marburg and Ebola viruses","volume":"47","author":"Feldmann","year":"1996","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ymthe.2025.08.022_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/21505594.2022.2054760","article-title":"Pathogenicity and virulence of Marburg virus","volume":"13","author":"Abir","year":"2022","journal-title":"Virulence"},{"key":"10.1016\/j.ymthe.2025.08.022_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.08.022_bib7","doi-asserted-by":"crossref","first-page":"S698","DOI":"10.1093\/infdis\/jiy213","article-title":"The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa","volume":"218","author":"Huber","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib8","first-page":"308","article-title":"Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.ymthe.2025.08.022_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(80)92352-1","article-title":"Inactivated vaccine for Ebola virus efficacious in guineapig model","volume":"2","author":"Lupton","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.08.022_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.08.022_bib11","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.08.022_bib12","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib13","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1073\/pnas.1316902111","article-title":"Vaccinating captive chimpanzees to save wild chimpanzees","volume":"111","author":"Warfield","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.08.022_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00226-y","article-title":"Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection","volume":"5","author":"Malherbe","year":"2020","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.08.022_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.08.022_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"Plos Med."},{"key":"10.1016\/j.ymthe.2025.08.022_bib17","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1093\/infdis\/jiw250","article-title":"An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates","volume":"214","author":"Wu","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib18","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib19","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1021\/mp500646d","article-title":"A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection","volume":"12","author":"Choi","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.08.022_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111935","article-title":"Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.08.022_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.774026","article-title":"Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease","volume":"12","author":"Marzi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/v16081181","article-title":"Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques","volume":"16","author":"Camargos","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.08.022_bib23","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A Recombinant Vesicular Stomatitis Virus Ebola Vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.08.022_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.08.022_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.coviro.2021.10.007","article-title":"Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity","volume":"51","author":"Pinski","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12080828","article-title":"Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo","volume":"12","author":"Choi","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.08.022_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11262-017-1455-x","article-title":"Ebola and Marburg virus vaccines","volume":"53","author":"Reynolds","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.ymthe.2025.08.022_bib29","article-title":"Therapeutic Strategies against Ebola Virus Infection","volume":"14","author":"Liu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.08.022_bib30","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1128\/JVI.77.21.11546-11554.2003","article-title":"A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice","volume":"77","author":"Combredet","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11262-017-1486-3","article-title":"Vaccine platform recombinant measles virus","volume":"53","author":"M\u00fchlebach","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.ymthe.2025.08.022_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles Vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.micinf.2018.01.005","article-title":"Measles-derived vaccines to prevent emerging viral diseases","volume":"20","author":"Frantz","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2025.08.022_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Despr\u00e8s","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2009.02.047","article-title":"Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic","volume":"388","author":"Guerbois","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2025.08.022_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3163","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","volume":"11","author":"Mateo","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.08.022_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.08.022_bib38","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus","volume":"31","author":"Brandler","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.08.022_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2018.08.014","article-title":"hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice","volume":"524","author":"Mura","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2025.08.022_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4939-6869-5_9","article-title":"Development of Recombinant Measles Virus-Based Vaccines","volume":"1581","author":"M\u00fchlebach","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib42","doi-asserted-by":"crossref","first-page":"S1053","DOI":"10.1093\/infdis\/jir346","article-title":"Advances in virus-like particle vaccines for filoviruses","volume":"204","author":"Warfield","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12257-022-0107-8","article-title":"Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application","volume":"28","author":"Zhang","year":"2023","journal-title":"Biotechnol. Bioproc. Eng."},{"key":"10.1016\/j.ymthe.2025.08.022_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/v15051109","article-title":"Virus-like Particle Vaccines and Platforms for Vaccine Development","volume":"15","author":"Kheirvari","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.08.022_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v12090923","article-title":"A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses","volume":"12","author":"Saito","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.08.022_bib46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.virs.2024.03.008","article-title":"A lethal mice model of recombinant vesicular stomatitis viruses for EBOV-targeting prophylactic vaccines evaluation","volume":"39","author":"Zhang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ymthe.2025.08.022_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virs.2024.03.010","article-title":"Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory","volume":"39","author":"Yang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ymthe.2025.08.022_bib48","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/514292","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"179","author":"Bray","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3748\/wjg.v21.i3.711","article-title":"Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine","volume":"21","author":"Sookoian","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103811","article-title":"Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1\/2 randomised, double-blind, placebo-controlled, dose-ranging trial","volume":"75","author":"Vanhoutte","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2025.08.022_bib52","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2018.07.076","article-title":"Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.08.022_bib53","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.08.022_bib54","article-title":"Design of immunogens to present a tumor-specific cryptic epitope","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.08.022_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01199-6","article-title":"Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity","volume":"10","author":"Vesin","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.08.022_bib56","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41564-024-01694-x","article-title":"Dynamics of measles immunity from birth and following vaccination","volume":"9","author":"Wang","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14090943","article-title":"Case Ascertainment of Measles during a Large Outbreak-Laboratory Compared to Epidemiological Confirmation","volume":"14","author":"Stein-Zamir","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.ymthe.2025.08.022_bib58","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.15585\/mmwr.mm7147a1","article-title":"Progress Toward Regional Measles Elimination - Worldwide, 2000-2021","volume":"71","author":"Minta","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ymthe.2025.08.022_bib59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/viro.2001.1012","article-title":"Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins","volume":"286","author":"Wilson","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2025.08.022_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms, advances, and technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2015.01.014","article-title":"Ebola and Marburg haemorrhagic fever","volume":"64","author":"Rougeron","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007564","article-title":"Complete protection of the BALB\/c and C57BL\/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine","volume":"15","author":"Rahim","year":"2019","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.08.022_bib63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on Th1\/Th2 cytokine balance","volume":"3","author":"Packard","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","article-title":"Th1\/Th2 cells","volume":"5","author":"Romagnani","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ymthe.2025.08.022_bib65","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2005.02931.x","article-title":"Correlations among measles virus-specific antibody, lymphoproliferation and Th1\/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination","volume":"142","author":"Dhiman","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2025.08.022_bib66","doi-asserted-by":"crossref","first-page":"32657","DOI":"10.1073\/pnas.2014468117","article-title":"A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine","volume":"117","author":"H\u00f6rner","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.08.022_bib67","doi-asserted-by":"crossref","first-page":"S682","DOI":"10.1093\/infdis\/jiad345","article-title":"AAV-Vectored Expression of Marburg Virus\u2013Neutralizing Antibody MR191 Provides Complete Protection From Challenge in a Guinea Pig Model","volume":"228","author":"Rghei","year":"2023","journal-title":"J. Infect. Dis."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625006525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625006525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:27:40Z","timestamp":1779524860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625006525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1525001625006525"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant live attenuated measles virus-based vaccines inducing comprehensive protection against Ebola and Marburg viruses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}